Literature DB >> 15855654

Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis.

G Astrid Limb1, Karl Matter, Gillian Murphy, Alison D Cambrey, Paul N Bishop, Glenn E Morris, Peng T Khaw.   

Abstract

Since the first description of matrix metalloproteinase (MMP)-1 as an interstitial collagenase, great importance has been ascribed to this enzyme in extracellular matrix remodeling during tumoral, inflammatory, and angiogenic processes. As more evidence for the role of MMPs in targeting nonmatrix substrates emerges, casual observations that intracellular MMP-1 is found in vitro and in vivo prompt investigation of the role that MMP-1 may play on basic cell functions such as cell division and apoptosis. Here we show for the first time that MMP-1 not only has extracellular functions but that it is strongly associated with mitochondria and nuclei and accumulates within the cells during the mitotic phase of the cell cycle. On induction of apoptosis, MMP-1 co-localized with aggregated mitochondria and accumulated around fragmented nuclei. Inhibition of this enzyme by RNA interference or treatment with a broad MMP inhibitor caused faster degradation of lamin A, activation of caspases, and fragmentation of DNA when compared with untreated cells. These observations strongly suggest that intracellular association of MMP-1 to mitochondria and nuclei confers resistance to apoptosis and may explain the well-known association of this enzyme with tumor cell survival and spreading.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855654      PMCID: PMC1606407          DOI: 10.1016/S0002-9440(10)62371-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.

Authors:  B E Bachmeier; A G Nerlich; R Lichtinghagen; C P Sommerhoff
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

3.  Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function.

Authors:  Spencer W Galt; Stephan Lindemann; Loren Allen; Donald J Medd; Jeanne M Falk; Thomas M McIntyre; Stephen M Prescott; Larry W Kraiss; Guy A Zimmerman; Andrew S Weyrich
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

4.  Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha.

Authors:  G Astrid Limb; Julie T Daniels; Robert Pleass; David G Charteris; Philip J Luthert; Peng T Khaw
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Authors:  Frank R Murphy; Razao Issa; Xiaoying Zhou; Shabna Ratnarajah; Hideaki Nagase; Michael J P Arthur; Christopher Benyon; John P Iredale
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

6.  In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1).

Authors:  G Astrid Limb; Thomas E Salt; Peter M G Munro; Stephen E Moss; Peng T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

7.  Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.

Authors:  B Lovejoy; A R Welch; S Carr; C Luong; C Broka; R T Hendricks; J A Campbell; K A Walker; R Martin; H Van Wart; M F Browner
Journal:  Nat Struct Biol       Date:  1999-03

8.  Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma.

Authors:  F Aoudjit; S Masure; G Opdenakker; E F Potworowski; Y St-Pierre
Journal:  Int J Cancer       Date:  1999-08-27       Impact factor: 7.396

9.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

10.  Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9.

Authors:  Katherine Conant; Norman Haughey; Avindra Nath; Coryse St Hillaire; Devin S Gary; Carlos A Pardo; Larry M Wahl; Masako Bilak; Elizabeth Milward; Mark P Mattson
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

View more
  38 in total

1.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

2.  Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.

Authors:  Neetu Tyagi; Jonathan C Vacek; Srikanth Givvimani; Utpal Sen; Suresh C Tyagi
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

3.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

4.  Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages.

Authors:  M Gloria Sans-Fons; Sonia Sole; Coral Sanfeliu; Anna M Planas
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats.

Authors:  Esma N Zeydanli; Ayca Bilginoglu; Evrim Tanriverdi; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

6.  Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.

Authors:  Karni S Moshal; Srinivas M Tipparaju; Thomas P Vacek; Munish Kumar; Mahavir Singh; Iluiana E Frank; Phani K Patibandla; Neetu Tyagi; Jayesh Rai; Naira Metreveli; Walter E Rodriguez; Michael T Tseng; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

7.  Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.

Authors:  Maria-Grazia Spiga; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

Review 8.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Authors:  Lidiya S Orlichenko; Derek C Radisky
Journal:  Clin Exp Metastasis       Date:  2008-02-20       Impact factor: 5.150

9.  Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.

Authors:  Karni S Moshal; Munish Kumar; Neetu Tyagi; Paras K Mishra; Naira Metreveli; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

10.  Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide.

Authors:  Nicholas A Pullen; Helen L Fillmore
Journal:  J Neurooncol       Date:  2009-07-21       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.